ATE305008T1 - Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen - Google Patents

Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen

Info

Publication number
ATE305008T1
ATE305008T1 AT00973591T AT00973591T ATE305008T1 AT E305008 T1 ATE305008 T1 AT E305008T1 AT 00973591 T AT00973591 T AT 00973591T AT 00973591 T AT00973591 T AT 00973591T AT E305008 T1 ATE305008 T1 AT E305008T1
Authority
AT
Austria
Prior art keywords
receptor antagonists
releasing hormone
hormone receptor
gonadotropin releasing
related uses
Prior art date
Application number
AT00973591T
Other languages
English (en)
Inventor
Yun-Fei Zhu
Timothy D Gross
Yinghong Gao
Patrick J Connors Jr
Zhiqiang Guo
Chen Chen
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Application granted granted Critical
Publication of ATE305008T1 publication Critical patent/ATE305008T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00973591T 1999-10-15 2000-10-16 Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen ATE305008T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41876899A 1999-10-15 1999-10-15
PCT/US2000/028677 WO2001029044A1 (en) 1999-10-15 2000-10-16 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto

Publications (1)

Publication Number Publication Date
ATE305008T1 true ATE305008T1 (de) 2005-10-15

Family

ID=23659500

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973591T ATE305008T1 (de) 1999-10-15 2000-10-16 Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen

Country Status (11)

Country Link
EP (1) EP1220857B1 (de)
JP (1) JP2003512379A (de)
KR (1) KR20020045609A (de)
AT (1) ATE305008T1 (de)
AU (1) AU769855B2 (de)
CA (1) CA2386942A1 (de)
DE (1) DE60022769T2 (de)
ES (1) ES2249302T3 (de)
HK (1) HK1047437B (de)
MX (1) MXPA02003614A (de)
WO (1) WO2001029044A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4931314B2 (ja) 2000-01-25 2012-05-16 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプタアンタゴニストおよびそれに関連した方法
US7288517B2 (en) 2001-04-30 2007-10-30 Aeterna Zentaris Gmbh Treatment of dementia and neurodegenerative diseases with intermediate doses of LHRH antagonists
EP1412363A1 (de) * 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Rezeptor antagonisten für gonadotropin-freisetzende hormone
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
MXPA04000986A (es) 2001-08-02 2005-02-17 Neurocrine Biosciences Inc 1,2,3-triazin-3,5-dionas sustituidas como antagonistas del receptor de hormona de liberacion de gonadotropina (gnrh).
JP2005505525A (ja) * 2001-08-02 2005-02-24 ニューロクライン バイオサイエンシーズ， インコーポレイテッド 性腺刺激ホルモン放出ホルモンレセプターアンタゴニストおよびそれに関連する方法
EP1411941A2 (de) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Pyridinon- und pyridazinonderivate als antagonisten des gonadotropin-freisetzungshormon-rezeptors
AU2003202115A1 (en) 2002-02-12 2003-09-04 Pfizer Inc. Non-peptide compounds affecting the action of gonadotropin-releasing hormone (gnrh)
BR0312123A (pt) 2002-06-13 2005-03-29 Pfizer Agentes de gnrh não peptìdicos, composições farmacêuticas e métodos para o seu uso
CN100376246C (zh) 2003-07-07 2008-03-26 纽罗克里生物科学有限公司 作为促性激素释放激素受体拮抗剂的嘧啶-2,4-二酮衍生物
WO2005007633A1 (en) 2003-07-07 2005-01-27 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
CN100424078C (zh) 2003-07-07 2008-10-08 纽罗克里生物科学有限公司 作为促性激素释放激素受体拮抗剂的嘧啶-2,4-二酮衍生物
CL2008000985A1 (es) 2007-04-06 2008-10-10 Neurocrine Biosciences Inc Compuesto derivado de heterociclos de nitrogeno, agonistas del receptor gnrh; composicion farmaceutica que comprende a dicho compuesto; y uso para tratar una afeccion relacionada con las hormonas sexuales, endometriosis, dismenorrea, enfermedad de ov
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
JP5637859B2 (ja) * 2007-12-13 2014-12-10 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 嚢胞性線維症膜コンダクタンスレギュレーターのモジュレーター
CN101987865B (zh) * 2009-07-29 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 含有乙内酰脲结构的促黄体生成素释放激素拮抗剂
TW201130854A (en) 2009-12-22 2011-09-16 Bayer Schering Pharma Ag Pyridinone derivatives and pharmaceutical compositions thereof
WO2012175514A1 (en) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
MX357841B (es) * 2012-02-28 2018-07-26 Tiumbio Co Ltd Antagonistas de los receptores de la hormona liberadora de gonadotropina, método para la preparación de éstos y composición farmacéutica que los contienen.
WO2014133112A1 (ja) * 2013-03-01 2014-09-04 国立大学法人東京大学 オートタキシン阻害活性を有する８－置換イミダゾピリミジノン誘導体
KR101973074B1 (ko) * 2018-11-30 2019-04-26 주식회사 티움바이오 퓨로피리미딘 화합물의 염 및 결정형, 및 이를 포함하는 약학적 조성물
MX2022006281A (es) 2019-11-25 2022-06-08 Amgen Inc Compuestos heterociclicos como inhibidores de delta-5 desaturasa y metodos de uso.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2300479A1 (en) * 1997-12-26 1999-07-08 Shuichi Furuya Nitrogen-containing heterocyclic compounds, their production and use
US6081508A (en) * 1998-02-25 2000-06-27 Indus River Networks, Inc. Remote computer communication
AU3118399A (en) * 1998-04-02 1999-10-25 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
ES2249302T3 (es) 2006-04-01
WO2001029044A1 (en) 2001-04-26
JP2003512379A (ja) 2003-04-02
AU1208901A (en) 2001-04-30
HK1047437B (zh) 2005-12-16
CA2386942A1 (en) 2001-04-26
DE60022769T2 (de) 2006-07-06
HK1047437A1 (en) 2003-02-21
AU769855B2 (en) 2004-02-05
EP1220857A1 (de) 2002-07-10
KR20020045609A (ko) 2002-06-19
MXPA02003614A (es) 2002-10-23
EP1220857B1 (de) 2005-09-21
DE60022769D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
ATE305008T1 (de) Gonadotropin freisetzenden hormon rezeptor antagonisten und ihre verwandten verwendungen
ATE548357T1 (de) Gonadotropin freisetzende hormon rezeptor antagonisten und ihre verwandten verfahren
IL172833A0 (en) Pyrimidine-2,4-dione derivatives and pharmaceutical compositions containing the same
IL172834A0 (en) Pyrimidine-,2,4-dione derivatives and pharmaceutical compositions containing the same
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
HUP0203870A2 (hu) Adenozinreceptor agonistát vagy antagonistát tartalmazó gyógyászati készítmény
WO2003011293A3 (en) Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
MX2009010828A (es) Antagonistas del receptor de la hormona liberadora de gonadotropina y metodos relacionados con los mismos.
ATE215081T1 (de) Gonadotropin releasing hormon- antagonisten
EP1106605A4 (de) Antagonisten des andrenergen-alpha1b-rezeptors
BR0110079A (pt) Combinação de compostos orgânicos
BR0317600A (pt) ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina
IL142893A0 (en) Fused polyclic heterocyclic compounds and pharmaceutical compositions containing the same
DE60208803D1 (de) 1,3,5-triazine-2,4,6-trione, herstellung und anwendungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
HUP0203844A2 (hu) Növekedési hormon kibocsátó tulajdonságú vegyület, ezt tartalmazó gyógyszerkészítmény és alkalmazása
EA200200831A1 (ru) Фармацевтическая композиция, включающая пеметрексед вместе с монотиоглицерином, l-цистеином или тиогликолевой кислотой
ATE557007T1 (de) Arylpyrimidine geeignet zur behandlung von sexualhormonbedingten zuständen wie endometriose, prostatakrebs und dergleichen
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
HK1072935A1 (en) Condensed camptothecins as antitumor agents
UA83870C2 (ru) Замещенные бицикло[3.1.1]гептаном производные бензимидазолона и хиназолинона как агонисты человеческих рецепторов orl1
DE60314158D1 (de) Pyrazolderivate als gnrh-inhibitoren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties